Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

80%

4 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4

3(60.0%)

Phase 3

1(20.0%)

N/A

1(20.0%)

5Total

Phase 4(3)

Phase 3(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT03283878Phase 4Completed

Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty- Multi-center Trial

Role: collaborator

NCT07357376Phase 3Not Yet Recruiting

Evaluating Suzetrigine for Pain Control Following TKA

Role: collaborator

NCT06636669Phase 4Enrolling By Invitation

Probiotics in the Prevention of Recurrent Prosthetic Joint Infection of the Hip and Knee

Role: collaborator

NCT06298721Not ApplicableRecruiting

Improving Total Knee Arthroplasty Dissatisfaction Through a Personalized Approach Focusing on PROMs Phenotypes

Role: collaborator

NCT03713528Phase 4Enrolling By Invitation

Can Intraosseous Antibiotics Improve the Results of Irrigation & Debridement and Prosthetic Retention for PJI?

Role: collaborator

All 5 trials loaded